Delving into the Latest Updates on Virbac AH, Inc. with Synapse

Overview

AbstractObjective—To determine whether an amitraz-impregnated collar could prevent transmission of Borrelia burgdorferi by Ixodes scapularis to dogs.Design—Laboratory trial.Animals—8 specific-pathogen-free Beagles.Procedure—On days –15 and –1, all dogs had negative ELISA results for serum antibodies against B burgdorferi. On day 0, 4 dogs were each fitted with an amitraz-impregnated (9%) collar, and 4 dogs served as untreated controls. On day 7, all dogs were infested with 100 I scapularis (approx 50 females and 50 males) with a known B burgdorferi infectivity rate of 39.4%. On days 21, 28, 35, 42, 56, 70, and 84, each dog was tested for serum antibodies against B burgdorferi via ELISA and a western blot technique. Additional ELISA were also performed for serum antibodies against antigenically similar organisms.Results—By day 70, all control dogs had developed serum ELISA responses ranging from 328 to 510 kinetics-ELISA units (equivalent to end-point titers of approx 43,500 to 60,000), whereas treated dogs remained seronegative throughout the study. Western blot assays performed on all serum samples confirmed that antibodies detected in control dogs reflected responses to specific antigens of B burgdorferi, whereas treated dogs had no such antibodies. Additional serologic analyses confirmed that antibody responses observed in control dogs were not attributable to antigenically similar organisms.Conclusions and Clinical Relevance—Amitrazimpregnated collars prevented transmission of B burgdorferi in 4 of 4 treated dogs and may be a useful management tool for prevention of borreliosis in dogs. (J Am Vet Med Assoc 2001;219:185–189)

100 Deals associated with Virbac AH, Inc.

Login to view more data

100 Translational Medicine associated with Virbac AH, Inc.

Login to view more data